Centinel Spine gets FDA nod for two-level use of prodisc C Nova

Centinel Spine has received the US FDA approval for two-level use of its prodisc C Nova cervical total disc replacement system. The FDA clearance permits the motion-preserving device to be implanted across two levels in the cervical spine. Centinel Spine concentrates exclusively on total disc replacement technologies for both cervical and lumbar spinal indications. Credit: Sai Thaw Kyar/Shutterstock.com. US-based commercial-stage medical technology firm Centinel Spine has received the US Food and Drug Administration (FDA) approval for two-level use of its prodisc C Nova cervical total disc replacement system. The regulatory clearance permits the motion-preserving device to be implanted across two…

Source: Medical Device Network